Drug class
Leucovorin (5-formyltetrahydrofolate); reduced folate analogue and folate rescue agent
Mechanism of action
Provides reduced folate downstream of dihydrofolate reductase, bypassing DHFR blockade and restoring tetrahydrofolate pools. It also potentiates fluorouracil by stabilising the thymidylate synthase–FdUMP complex.
General use cases
- Rescue after high-dose methotrexate therapy and treatment of folate-antagonist toxicity
- In combination with fluorouracil to enhance antitumour activity in colorectal cancer regimens
- Treatment of selected megaloblastic anaemias due to folate deficiency when parenteral therapy is needed; not a substitute for folic acid in routine prevention
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
